Bath & Body Works (NYSE:BBWI - Get Free Report) had its target price dropped by analysts at The Goldman Sachs Group from $26.00 to $23.00 in a report released on Thursday,Benzinga reports. The brokerage currently has a "neutral" rating on the stock. The Goldman Sachs Group's price objective would suggest a potential upside of 17.56% from the stock's previous close.
A number of other equities analysts have also weighed in on the stock. UBS Group decreased their price objective on shares of Bath & Body Works from $22.00 to $19.00 and set a "neutral" rating for the company in a report on Wednesday, May 20th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Bath & Body Works from $21.00 to $22.00 and gave the stock a "hold" rating in a report on Tuesday, March 3rd. Barclays set a $23.00 target price on shares of Bath & Body Works in a research report on Thursday. TD Cowen cut their price objective on shares of Bath & Body Works from $26.00 to $20.00 and set a "buy" rating for the company in a research report on Monday, May 18th. Finally, Citigroup downgraded shares of Bath & Body Works from a "buy" rating to a "neutral" rating and boosted their price objective for the company from $21.00 to $25.00 in a research report on Tuesday, February 17th. Three equities research analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $21.79.
Get Our Latest Stock Analysis on Bath & Body Works
Bath & Body Works Stock Performance
BBWI stock opened at $19.56 on Thursday. The firm has a 50 day moving average price of $18.65 and a 200-day moving average price of $20.24. Bath & Body Works has a 52-week low of $14.27 and a 52-week high of $33.96. The firm has a market capitalization of $3.94 billion, a price-to-earnings ratio of 6.21, a PEG ratio of 1.76 and a beta of 1.43.
Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings data on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, topping analysts' consensus estimates of $0.29 by $0.03. Bath & Body Works had a net margin of 8.90% and a negative return on equity of 45.60%. The company had revenue of $1.38 billion during the quarter, compared to analyst estimates of $1.36 billion. During the same period in the previous year, the business earned $0.49 EPS. The firm's revenue for the quarter was down 3.2% on a year-over-year basis. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. As a group, sell-side analysts forecast that Bath & Body Works will post 2.61 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Hedge funds have recently bought and sold shares of the company. Gabelli Funds LLC lifted its stake in Bath & Body Works by 1.2% in the 3rd quarter. Gabelli Funds LLC now owns 47,536 shares of the company's stock worth $1,225,000 after purchasing an additional 542 shares in the last quarter. Parallel Advisors LLC lifted its stake in Bath & Body Works by 42.6% in the 4th quarter. Parallel Advisors LLC now owns 1,897 shares of the company's stock worth $38,000 after purchasing an additional 567 shares in the last quarter. State of Michigan Retirement System lifted its stake in Bath & Body Works by 1.2% in the 1st quarter. State of Michigan Retirement System now owns 49,300 shares of the company's stock worth $920,000 after purchasing an additional 600 shares in the last quarter. Meeder Asset Management Inc. lifted its stake in Bath & Body Works by 28.5% in the 4th quarter. Meeder Asset Management Inc. now owns 2,874 shares of the company's stock worth $58,000 after purchasing an additional 637 shares in the last quarter. Finally, State of Wyoming lifted its stake in Bath & Body Works by 6.2% in the 2nd quarter. State of Wyoming now owns 11,294 shares of the company's stock worth $338,000 after purchasing an additional 661 shares in the last quarter. Institutional investors own 95.14% of the company's stock.
Bath & Body Works News Summary
Here are the key news stories impacting Bath & Body Works this week:
About Bath & Body Works
(
Get Free Report)
Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.
Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.